Empyrean Therapeutics Ltd is a research and experimental development company focused on biotechnology solutions within the Cambridgeshire region of England, UK. Founded in May 2018 under Regulatory Number 11372447, Empyrean specializes in providing tailored services to pharmaceutical companies seeking to accelerate drug discovery and development processes. The company operates as a limited liability company (Ltd) with a core focus on biotechnology innovation. Currently, Empyrean’s primary service offering is the identification of potential therapeutic targets and novel compounds for clients. They provide expert consultation across various areas including preclinical studies, formulation optimization, and analytical method development. The company actively collaborates with established pharmaceutical firms located in Cambridgeshire, notably Bicycle Therapeutics, Ieso, and Abzena, fostering a network of verified contacts within the industry. Empyrean’s international presence is currently limited to no direct operations outside the UK, reflecting its strategic focus on domestic research and development. Employees are skilled workers with an A rating, indicating a commitment to their roles and responsibilities. The company regularly updates its portfolio of featured companies to maintain relevance within the biotechnology sector.

Empyrean Therapeutics Ltd is a research and experimental development company focused on biotechnology solutions within the Cambridgeshire region of England, UK. Founded in May 2018 under Regulatory Number 11372447, Empyrean specializes in providing tailored services to pharmaceutical companies seeking to accelerate drug discovery and development processes. The company operates as a limited liability company (Ltd) with a core focus on biotechnology innovation. Currently, Empyrean’s primary service offering is the identification of potential therapeutic targets and novel compounds for clients. They provide expert consultation across various areas including preclinical studies, formulation optimization, and analytical method development. The company actively collaborates with established pharmaceutical firms located in Cambridgeshire, notably Bicycle Therapeutics, Ieso, and Abzena, fostering a network of verified contacts within the industry. Empyrean’s international presence is currently limited to no direct operations outside the UK, reflecting its strategic focus on domestic research and development. Employees are skilled workers with an A rating, indicating a commitment to their roles and responsibilities. The company regularly updates its portfolio of featured companies to maintain relevance within the biotechnology sector.